Barriers to Asthma Treatment in the United States: Results From the Global Asthma Physician and Patient Survey

World Allergy Organization Journal

Giorgio W Canonica¹  Erkka J Valovirta⁴  Ronald Dahl⁶  Carlos E Baena-Cagnani⁵  Michael A Kaliner²  Michael S Blaiss³ 

[1] Allergy and Respiratory Diseases Clinic, University of Genova DIMI, Genova, Italy;Institute for Asthma and Allergy, Chevy Chase, MD;University of Tennessee Health Science Center, Memphis, TN;Turku Allergy Center, Turku, Finland;Centre of Respiratory Medicine and Allergy. Chutro Clinic Córdoba, Córdoba, Argentina;Aarhus University Hospital, Department of Respiratory Diseases, Aarhus, Denmark

关键词: asthma education;    asthma management;    compliance;    Global Asthma Physician and Patient (GAPP) Survey;    side-effects;    inhaled corticosteroids;    asthma;   

Others  :  1180811
DOI  :  10.1097/WOX.0b013e3181c81ea4

【 摘 要 】

Background

The Global Asthma Physician and Patient (GAPP) survey evaluated the perceptions of both physicians and patients on the management of asthma. Here we present the results from the United States (US) subpopulation of the GAPP survey.

Methods

The GAPP Survey was a large, global study (physicians, n = 1733; patients, n = 1726; interviews, n = 3459). In the US, 208 adults (aged ≥ 18 years) with asthma and 224 physicians were recruited. Respondents were questioned using self-administered online interviews with close-ended questionnaires.

Results

Physician and patient responses were found to differ in regard to perception of time spent on asthma education, awareness of disease symptoms and their severity, asthma medication side effects, and adherence to treatment and the consequence of nonadherence. Comparison of the US findings with the global GAPP survey results suggest the US physician-patient partnership compared reasonably well with the other countries in the survey. Both patients and physicians cited a need for new asthma medication.

Conclusions

Similar to the global GAPP survey, the US-specific findings indicate that in general there is a lack of asthma control, poor adherence to therapy, and room for improvement in patient-physician communication and partnership in treating asthma.

【 授权许可】

   
2009 World Allergy Organization; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]GINA: the global initiative for asthma 2008. Available at: http://www.ginasthma.org/ webcite Accessed May 13, 2009
• [2]Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, et al.: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
• [3]Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004, 59:469-478.
• [4]Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, et al.: World-wide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114:40-47.
• [5]Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, et al.: The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001, 54:610-618.
• [6]Lenney W: The burden of pediatric asthma. Pediatr Pulmonol Suppl 1997, 15:13-16.
• [7]Nocon A, Booth T: The social impact of asthma. Fam Pract 1991, 8:37-41.
• [8]Lenfant C: National asthma education and prevention program: Expert panel report. Guidelines for the diagnosis and management of asthma update on selected topics, 2002. JACI 2002, 10(Suppl):S141-S219.
• [9]Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F: Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol 2002, 110:58-64.
• [10]Yuksel N, Ginther S, Man P, Tsuyuki RT: Underuse of inhaled corticosteroids in adults with asthma. Pharmacotherapy 2000, 20:387-393.
• [11]Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, et al.: Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004, 114:1288-1293.
• [12]Canonica GW, Baena-Cagnani CE, Blaiss MS, Dahl R, Kaliner MA, Valovirta EJ: Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy 2007, 62:668-674.
• [13]Harris Interactive 2009. Available at: http://www.harrisinteractive.com/services/healthcare/asp webcite. Accessed Oct 15, 2009
• [14]Gillissen A: Managing asthma in the real world. Int J Clin Pract 2004, 58:592-603.
• [15]Moffat M, Cleland J, van der Molen T, Price D: Poor communication may impair optimal asthma care: a qualitative study. Fam Pract 2007, 24:65-70.
• [16]Moffat M, Cleland J, van der Molen T, Price D: Sub-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma. Prim Care Respir J 2006, 15:159-165.
• [17]Halm EA, Mora P, Leventhal H: No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest 2006, 129:573-580.
• [18]Bender BG, Bender SE: Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am 2005, 25:107-130.
• [19]Ulrik CS, Backer V, Soes-Petersen U, Lange P, Harving H, Plaschke PP: The patient's perspective: adherence or non-adherence to asthma controller therapy? J Asthma 2006, 43:701-704.
• [20]Howell G: Nonadherence to medical therapy in asthma: risk factors, barriers, and strategies for improving. J Asthma 2008, 45:723-729.
• [21]Horne R: Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006, 130(Suppl):65S-72S.
• [22]Irwin RS, Richardson ND: Patient-focused care: using the right tools. Chest 2006, 130(Suppl):73S-82S.
• [23]Muhlhauser I, Richter B, Kraut D, Weske G, Worth H, Berger M: Evaluation of a structured treatment and teaching programme on asthma. J Intern Med 1991, 230:157-164.
• [24]Janson SL, Fahy JV, Covington JK, Paul SM, Gold WM, Boushey HA: Effects of individual self-management education on clinical, biological, and adherence outcomes in asthma. Am J Med 2003, 115:620-626.
• [25]Gibson PG, Ram FS, Powell H: Asthma education. Respir Med 2003, 97:1036-1044.
• [26]Heiner MM: Key barriers to optimal management of adult asthma in Australia: physician and patient perspectives. Curr Med Res Opin 2007, 23:1799-1807.
• [27]Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, et al.: Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004, 114:40-47.
• [28]Kellerman R: The patient centered medical home: a new model of practice in the USA. Aust Fam Physician 2009, 38:279.
• [29]Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A: Improving chronic illness care: translating evidence into action. Health Affairs 2001, 20:64-78.
• [30]Stewart M, Brown JB, Weston WW, McWhinney IR, McWilliam CL, Freeman TR: Patient-centered medicine: transforming the clinical method. International Journal of Integrated Care Second edition. 2005, 5:1-2.